AccessibilityHelp
Rhelion Life Sciences logo

Rhelion Life Sciences(OTC) TRUFF

Market Cap$10.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-74%
5 Year-89%
1 Year-23%
1 Month-28%
$0.02
-2.25%
-0.00Today
Rhelion Life Sciences last closing stock price
MetricPriceDate
Last closeUSD 0.022026-10-23
Rhelion Life Sciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5%USD 0.022026-10-16
1 month-27.73%USD 0.022026-09-23
3 month-18.12%USD 0.022026-07-24
Year to date+9.64%USD 0.022025-12-31
1 year-23.39%USD 0.022025-10-23
3 year-60.33%USD 0.052023-10-24
5 year-89.44%USD 0.172021-10-22
Since inception-73.87%USD 0.072020-07-17

Rhelion Life Sciences Financials at a Glance

Market Cap

$10.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$3.08M

Net Income (TTM)

-CA$6.57M

EPS (TTM)

-$0.01

P/E Ratio

-1.67

Dividend

$0.00

Beta (Volatility)

0.48 (Low)

Price

$0.02

Volume

12,297

Open

$0.03

Previous Close

$0.02

Daily Range

$0.02 - $0.03

52-Week Range

$0.01 - $0.04

Estimated Earnings Date

Nov 30, 2026

TRUFF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rhelion Life Sciences

Rhelion Life Sciences Corp. is a company focused on the cultivation, manufacturing, and commercialization of magic truffles for the leisure market in the Netherlands. The company also engages in sourcing and distributing a variety of products, including CBD items and cannabis-infused baked goods.

Products and Services
  • Magic truffles for the leisure market
  • CBD products and cannabis seeds
  • Cannabis-infused bakery items like cookies and muffins
Growth Outlook
  • Expansion into international markets is underway
  • Increasing demand for CBD products supports growth potential
  • Plans to enhance e-commerce capabilities to boost sales
Financial Highlights
  • Recent quarterly revenue of CAD 186,150 shows potential for recovery
  • Trailing twelve months (TTM) revenue of CAD 3,000,000 indicates a solid market presence
  • Current ratio of 3.98 suggests strong liquidity position
Rhelion Life Sciences Corp. operates in the dynamic drug manufacturing sector, particularly focusing on specialty and generic products. The company's diverse product offerings cater to a growing market, particularly in the Netherlands, where the demand for leisure and wellness products is on the rise. The recent quarterly revenue indicates a potential recovery trajectory, while the TTM revenue reflects a solid market presence. The company's strong liquidity position, as evidenced by a current ratio of 3.98, provides a buffer for operational flexibility. With plans for international expansion and enhanced e-commerce capabilities, Rhelion Life Sciences Corp. is well-positioned to capitalize on emerging market trends.
AI Generated • Sep 27, 2026

Industry

Food Products

Sector

Consumer Staples

CEO

Todd Michael Shapiro

Website

www.redlight.co

Headquarters

Toronto, ON M5C 2V9, CA

TRUFF Financials

Key Financial Metrics (TTM)

Gross Margin

31.66%

Operating Margin

-105.56%

Net Income Margin

-145.45%

Return on Equity

-41.33%

Return on Capital

-30.82%

Return on Assets

-41.88%

Earnings Yield

-59.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

614.13M

Volume

12.30K

Avg. Volume

121.78K

Financials (TTM)

Gross Profit

CA$1.13M

Operating Income

-CA$8.12M

EBITDA

-CA$4.58M

Operating Cash Flow

-CA$2.91M

Capital Expenditure

-CA$1.09M

Free Cash Flow

-CA$4.00M

Cash & ST Invst.

CA$8.13M

Total Debt

CA$288.82K

Rhelion Life Sciences Performance Analysis

Rhelion Life Sciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 2,985,64961.0%
20242024-03-31CAD 3,523,03918.0%
20252025-03-31CAD 3,554,7080.9%
20262026-03-31CAD 3,035,512-14.6%
Rhelion Life Sciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-42.0%
Q32025-12-3167.6%
Q42026-03-31-30.7%
Q12026-06-30-78.7%
Rhelion Life Sciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -0.01-66.6%
20242024-03-31CAD -0.0131.2%
20252025-03-31CAD -0.01-49.7%
20262026-03-31CAD -0.0147.2%
Rhelion Life Sciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-12.0%
Q32025-12-31-17.9%
Q42026-03-31-84.8%
Q12026-06-3055.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

CA$186.15K

-85.7%

Gross Profit

CA$74.78K

-83.3%

Gross Margin

40.17%

N/A

Market Cap

$10.96MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$105.40K

N/A

Employees

104

N/A

Net Income

-CA$1.50M

-45.6%

EBITDA

-CA$1.34M

-40.8%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

CA$8.13M

-30.3%

Total Debt

CA$288.82K

-81.1%

Accounts Receivable

CA$454.55K

-6.7%

Inventory

CA$381.53K

-62.4%

Long Term Debt

CA$207.56K

-32.5%

Short Term Debt

CA$81.26K

-93.3%

Return on Assets

-41.88%

N/A

Return on Invested Capital

-38.70%

N/A

Free Cash Flow

-CA$889.44K

-66.2%

Operating Cash Flow

-CA$889.44K

-120.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EGRXEagle Pharmaceuticals, Inc.
$0.95-5.00%
BGXXBright Green Corporation
$0.04+5328.57%
MMJJFUnderwood Capital Limited
$0.03+0.00%
UDOCFUnidoc Health Corp.
$0.05-17.24%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$12.59-16.95%
EWZiShares - iShares Msci Brazil ETF
$34.15-19.82%
ITUBItaú Unibanco
$7.70-20.37%
XPXP
$15.71-48.36%

Questions About TRUFF

What is the current price of Rhelion Life Sciences?

Rhelion Life Sciences is trading at $0.02 per share.

What is the 52-week range for Rhelion Life Sciences?

Over the past 52 weeks, Rhelion Life Sciences has traded between $0.01 and $0.04.

How much debt does Rhelion Life Sciences have?

As of the most recent reporting period, Rhelion Life Sciences reported total debt of CA$203.49K.

How much cash does Rhelion Life Sciences have on hand?

Rhelion Life Sciences reported CA$1.83M in cash and cash equivalents in its most recent financial results.

What is Rhelion Life Sciences’s dividend yield?

Rhelion Life Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services